Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
NovoCure Limited stock logo
NVCR
NovoCure
$17.49
-0.6%
$15.31
$9.82
$18.92
$2.04B0.931.41 million shs1.02 million shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$25.11
-3.1%
$23.22
$12.56
$28.53
$1.79B1.65293,458 shs269,602 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$22.10
-4.8%
$25.74
$19.35
$62.17
$1.32B0.851.28 million shs3.47 million shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
$19.01
$535.71M2.17444,551 shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
NovoCure Limited stock logo
NVCR
NovoCure
-1.01%+4.45%+0.11%+42.51%+0.28%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
+6.36%+4.35%+5.58%+16.13%+64.36%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-9.65%-18.10%-11.10%-15.13%-61.70%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+108.68%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
NovoCure Limited stock logo
NVCR
NovoCure
$17.49
-0.6%
$15.31
$9.82
$18.92
$2.04B0.931.41 million shs1.02 million shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$25.11
-3.1%
$23.22
$12.56
$28.53
$1.79B1.65293,458 shs269,602 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$22.10
-4.8%
$25.74
$19.35
$62.17
$1.32B0.851.28 million shs3.47 million shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
$19.01
$535.71M2.17444,551 shsN/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
NovoCure Limited stock logo
NVCR
NovoCure
-1.01%+4.45%+0.11%+42.51%+0.28%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
+6.36%+4.35%+5.58%+16.13%+64.36%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-9.65%-18.10%-11.10%-15.13%-61.70%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+108.68%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
NovoCure Limited stock logo
NVCR
NovoCure
2.38
Hold$27.2956.01% Upside
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
2.50
Moderate Buy$30.6722.13% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.36
Hold$41.3687.17% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
1.67
Reduce$19.000.05% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, NVCR, PLSE, and PRCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/11/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
DowngradeOutperformMarket Perform$31.00 ➝ $29.00
6/4/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Initiated CoverageBuy$32.00
6/1/2026
NovoCure Limited stock logo
NVCR
NovoCure
UpgradeSell (E+)Sell (D-)
5/4/2026
NovoCure Limited stock logo
NVCR
NovoCure
Boost Price TargetEqual Weight$13.50 ➝ $17.00
5/1/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingOutperform
4/30/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Reiterated RatingOverweight$28.00 ➝ $35.00
4/21/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingSell (E+)
4/21/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Reiterated RatingSell (D-)
4/21/2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
Reiterated RatingSell (E+)
4/16/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingNeutral$18.00
(Data available from 6/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
NovoCure Limited stock logo
NVCR
NovoCure
$655.35M3.09N/AN/A$3.04 per share5.75
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$350K4,965.32N/AN/A$1.19 per share21.10
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$308.05M4.08N/AN/A$6.55 per share3.37
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.86 per share10.22$13.83 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
NovoCure Limited stock logo
NVCR
NovoCure
-$136.23M-$1.53N/AN/AN/A-25.66%-50.82%-16.48%7/23/2026 (Estimated)
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$72.78M-$1.10N/AN/AN/AN/A-86.67%-73.61%8/11/2026 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$1.82N/AN/AN/A-31.82%-27.70%-20.29%8/5/2026 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/AN/A-4.39%6.37%3.34%N/A

Latest ZIMV, NVCR, PLSE, and PRCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/4/2026Q1 2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$0.32-$0.27+$0.05-$0.27$0.25 million$0.40 million
4/30/2026Q1 2026
NovoCure Limited stock logo
NVCR
NovoCure
-$0.5122-$0.62-$0.1078-$0.62$167.77 million$174.06 million
4/29/2026Q1 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.55-$0.56-$0.01-$0.56$80.52 million$83.13 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
NovoCure Limited stock logo
NVCR
NovoCure
0.71
2.90
2.70
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A
7.26
7.24
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.15
6.73
5.51
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
76.95%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
74.00%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
17.40%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,605115.82 million109.43 millionOptionable
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
14069.21 million18.00 millionOptionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43056.92 million47.02 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.21 million26.69 millionNo Data

Recent News About These Companies

ZimVie Inc.
Inogen adds med tech vet to board
ZimVie Board Backs Year-End Transaction
ZimVie Inc Completes Acquisition by ARCHIMED
ZimVie Announces Completion of its Acquisition by ARCHIMED
Inside 4 orthopedic medtech splinters
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
ZimVie Inc Faces Legal Challenges Over Merger

New MarketBeat Followers Over Time

Media Sentiment Over Time

NovoCure stock logo

NovoCure NASDAQ:NVCR

$17.49 -0.11 (-0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$17.24 -0.24 (-1.40%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$25.11 -0.81 (-3.13%)
Closing price 04:00 PM Eastern
Extended Trading
$24.90 -0.21 (-0.84%)
As of 06:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$22.10 -1.12 (-4.82%)
Closing price 04:00 PM Eastern
Extended Trading
$22.73 +0.63 (+2.85%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.